BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

843 related articles for article (PubMed ID: 28953211)

  • 21. Prophylactic central neck dissection for cN0 papillary thyroid carcinoma: is there any difference between western countries and China? A systematic review and meta-analysis.
    Yang J; Han Y; Min Y; Chen C; Chen J; Xiang K; Liao J; Feng Y; Hu D; Yin G
    Front Endocrinol (Lausanne); 2023; 14():1176512. PubMed ID: 37576962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Noninferior response in BRAF(V600E) mutant nonmetastatic papillary thyroid carcinoma to radioiodine therapy.
    Li J; Liang J; Zhao T; Lin Y
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1034-9. PubMed ID: 26780618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of central neck dissection for cN0 papillary thyroid carcinoma.
    Giordano D; Frasoldati A; Gabrielli E; Pernice C; Zini M; Castellucci A; Piana S; Ciarrocchi A; Cavuto S; Barbieri V
    Am J Otolaryngol; 2017; 38(5):576-581. PubMed ID: 28599790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of prophylactic central lymph node dissection on the complications and recurrence rates in papillary thyroid carcinoma-An AFCE (French-speaking Association of Endocrine Surgery) multicentre study based on the EUROCRINE® national data.
    Chereau N; Christou N; Caiazzo R; Le Fouler A; Lifante JC; Maillard L; Mirallie E; Pattou F; Bouviez N; Santucci N; Brunaud L; Menegaux F
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1993. PubMed ID: 38351532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term impact of prophylactic central neck dissection in non-invasive classic papillary thyroid carcinoma.
    Xu Z; Mao Z; Chen S; Mo Z; Zhou J; Chen Z; Zarnegar R; Fahey Iii TJ; Wang W; Teng L
    Eur J Surg Oncol; 2024 Jan; 50(1):107305. PubMed ID: 38070466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of prophylactic central neck lymph node dissection on early recurrence in papillary thyroid carcinoma.
    Moo TA; McGill J; Allendorf J; Lee J; Fahey T; Zarnegar R
    World J Surg; 2010 Jun; 34(6):1187-91. PubMed ID: 20130868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer.
    Ruel E; Thomas S; Perkins JM; Roman SA; Sosa JA
    Ann Surg Oncol; 2017 Jul; 24(7):1935-1942. PubMed ID: 28127652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
    Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
    Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer--is there a need for radioactive iodine therapy?
    Ibrahimpasic T; Nixon IJ; Palmer FL; Whitcher MM; Tuttle RM; Shaha A; Patel SG; Shah JP; Ganly I
    Surgery; 2012 Dec; 152(6):1096-105. PubMed ID: 23158181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.
    Sippel RS; Robbins SE; Poehls JL; Pitt SC; Chen H; Leverson G; Long KL; Schneider DF; Connor NP
    Ann Surg; 2020 Sep; 272(3):496-503. PubMed ID: 33759836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is Postoperative Adjuvant Radioactive Iodine Ablation Therapy Always Necessary for Intermediate-Risk Papillary Thyroid Cancer Patients With Central Neck Metastasis?
    Han K; Noh HM; Jeong HM; Lim YC
    Ann Surg Oncol; 2021 Nov; 28(12):7533-7544. PubMed ID: 34043093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nodal recurrence in the lateral neck after total thyroidectomy with prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Langenbecks Arch Surg; 2014 Feb; 399(2):237-44. PubMed ID: 24213969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma.
    Henry JF; Gramatica L; Denizot A; Kvachenyuk A; Puccini M; Defechereux T
    Langenbecks Arch Surg; 1998 Apr; 383(2):167-9. PubMed ID: 9641892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
    Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
    Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-risk papillary thyroid carcinoma patients who underwent near-total thyroidectomy without prophylactic central compartment lymph node dissection and were ablated with low-dose 50mCi RAI had excellent 10-year prognosis.
    Michalaki M; Bountouris P; Roupas ND; Theodoropoulou A; Agalianou N; Alexandrides T; Markou K
    Hormones (Athens); 2016 Oct; 15(4):511-517. PubMed ID: 28222412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prophylactic Central Neck Dissection for Clinically Node-Negative Papillary Thyroid Carcinoma.
    Alsubaie KM; Alsubaie HM; Alzahrani FR; Alessa MA; Abdulmonem SK; Merdad MA; Al-Khatib T; Marzouki HZ; Algarni MA; Alherabi AZ
    Laryngoscope; 2022 Jun; 132(6):1320-1328. PubMed ID: 34708877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.